My Retina Tracker® Panel
A comprehensive 110-gene panel designed to identify pathogenic variants associated with inherited retinal degenerations and related retinal dystrophies.
Accessed through the My Retina Tracker® Sponsored Testing Program•Sponsored by Foundation Fighting Blindness•Performed by Prevention Genetics
Designed to support clinical decision-making and ordering in your practice.
For healthcare providers
Overview
The My Retina Tracker Program, sponsored by the Foundation Fighting Blindness, provides no-cost NGS-based genetic testing via a 110-gene panel for patients with a clinically confirmed inherited retinal disease. The program supports molecular diagnosis to inform management, identify candidates for gene-directed therapies, and facilitate clinical trial matching. Genetic counseling is included as part of the sponsored program, and results are contributed to the My Retina Tracker Registry to advance IRD research.
When to consider this test
Patient selection
- Residency: Patient resides in the U.S. or a U.S. territory.
- Clinical criteria: Patient has a clinically confirmed IRD eligible for the program.
- Family status: Patient has no first-degree relatives previously tested through the Program.
- Prior testing: Patient has not undergone an IRD panel of 32+ genes, WES, or WGS within the last 5 years.
- Prior results: Patient has not received an IRD-related molecular diagnosis from any previous testing.
- Registry requirement: Patient agrees to enroll in the My Retina Tracker Registry and allow results to be shared.
- Familial variant testing: Relatives of individuals with a positive or indeterminate Program result may qualify for no-cost targeted variant testing.
Workflow
How to use this program
- 1
Apply for Participation
Submit the provider application to the Foundation Fighting Blindness. Approval is required before you can order testing through the Program.
- 2
Create a Program Account
Set up your Program-specific account here. Ordering access will be granted after the Foundation processes your request.
- 3
Share Program Materials
Use the Program webform link provided by the Foundation to submit patient details. Patients receive study materials and consent forms via email.
- 4
Download Patient’s HIPAA Form
Once the patient signs electronically, you will receive the executed HIPAA release by email. Download and save it for the test requisition form.
- 5
Complete the TRF
Access the Program portal to enter clinical information, upload the HIPAA release, and select your genetic counseling preference—this choice cannot be changed later.
- 6
Determine Sample Collection
Collect the sample in clinic or request a kit be mailed to the patient. Label specimens with at least two identifiers. Deliveries are accepted Monday–Saturday.
- 7
Review Results and Counsel
Results are typically returned in about 21 days. Discuss results with the patient or coordinate post-test counseling through InformedDNA, based on your selection.
Billing overview
Program billing
For eligible patients, the sponsor has arrangements with the laboratory that may reduce or cover some or all of the patient's out-of-pocket cost. Actual cost and patient responsibility vary by program criteria. Refer to lab or sponsor materials for details.
Quality & privacy
Laboratory quality & data handling
Testing is performed by Prevention Genetics, a CLIA-certified laboratory (CLIA 52D2065132) and College of American Pathologists (CAP) certified laboratory (CAP 7185561). Your sample is processed using validated methods and quality controls to support reliable genetic results.
Your health information is handled under privacy and security practices that are intended to align with applicable regulations. For program- and lab-specific details, review the privacy information provided by the laboratory and sponsor.
FAQ
Frequently asked questions
Which patients are appropriate for the My Retina Tracker inherited retinal disease genetic testing program?
The My Retina Tracker Program is designed for patients with a clinically confirmed diagnosis of an inherited retinal disease who meet the program's eligibility criteria. Patients must reside in the United States or a U.S. territory. Familial variant testing may also be available at no cost for biological relatives of individuals who received a positive or, in some cases, indeterminate result through the program.
What does the My Retina Tracker 110-gene panel cover and what methodology is used?
The My Retina Tracker Panel is a 110-gene next-generation sequencing (NGS) panel targeting genes associated with inherited retinal diseases. Testing is performed by PreventionGenetics (a wholly owned subsidiary of Abbott) in their CAP-accredited, CLIA-certified laboratory in Marshfield, Wisconsin. The panel is intended to establish a molecular diagnosis that can guide clinical management and identify eligibility for gene-directed therapies or clinical research.
What specimen types are accepted and what is the turnaround time for the My Retina Tracker IRD panel?
The My Retina Tracker Program accepts whole blood, saliva, or OCD-100 buccal swab specimens. Turnaround time is approximately 2 to 3 weeks from specimen receipt at PreventionGenetics. Ordering and specimen shipping logistics are coordinated through the program workflow.
Is genetic counseling included with the My Retina Tracker Program for inherited retinal diseases?
Yes, the My Retina Tracker Program includes genetic counseling as part of the sponsored testing at no cost to the patient or the ordering provider. Counseling support is available to help interpret results and discuss implications for the patient and at-risk family members.
Is there any cost or prescribing obligation when ordering the My Retina Tracker inherited retinal disease panel?
There is no cost to the patient or the ordering clinician for the My Retina Tracker Program. The Foundation Fighting Blindness fully sponsors the testing, including the 110-gene panel and genetic counseling. Ordering through the program carries no purchase or prescribing obligation. Patients must enroll through the program workflow and complete all required consent and HIPAA documentation.
How does the My Retina Tracker Registry relate to the genetic testing program?
Participants in the My Retina Tracker Program agree to join the My Retina Tracker Registry and share their genetic testing results with it. The Registry, maintained by the Foundation Fighting Blindness, aggregates genotype-phenotype data to support IRD research, advance clinical trial recruitment, and accelerate therapeutic development. This registry participation is a condition of enrollment in the no-cost testing program.
Which patients are eligible for My Retina Tracker Inherited Retinal Disease genetic testing?
Patients may qualify for My Retina Tracker if they meet the program's eligibility criteria:
- Residency: Patient resides in the U.S. or a U.S. territory.
- Clinical criteria: Patient has a clinically confirmed IRD eligible for the program.
- Family status: Patient has no first-degree relatives previously tested through the Program.
- Prior testing: Patient has not undergone an IRD panel of 32+ genes, WES, or WGS within the last 5 years.
- Prior results: Patient has not received an IRD-related molecular diagnosis from any previous testing.
- Registry requirement: Patient agrees to enroll in the My Retina Tracker Registry and allow results to be shared.
- Familial variant testing: Relatives of individuals with a positive or indeterminate Program result may qualify for no-cost targeted variant testing.
See an issue with this program?